Press Release 2022 - Sami-Sabinsa Group | Formerly Known as Sami Labs Limited

Disclaimer

Please note that this website and information provided herein is not for final consumers of a finished food, beverage, dietary supplement product or cosmetic product, as the information contained herein does not refer to finished products for consumers.

The information provided on the website is intended only for producers of finished food, beverage, dietary supplement and cosmetic product.

The statements related to ingredients on the website, have not been evaluated by the Food and Drug Administration and are not intended to diagnose, treat, cure, or prevent any disease.

The website and information herein are available in various countries across the world, and hence statements or product information including its classification may not be applicable in your country.

Information and statements provided on the website, shall not be construed as license to practice, or recommendations to infringe, any patents or other intellectual property rights of Sabinsa and others.

By browsing further, You understand the above terms.

Sabinsa to Showcase Innovative Nutraceutical and Cosmeceutical Ingredients at Bio Asia-Taiwan Exhibition

Sami-Sabinsa Founder Expresses Sadness on Passing of CEO V.G. Nair

Sami-Sabinsa to Showcase Innovative Ingredients at Nutraceuticals Europe Summit & Expo (Spain)

Sami-Sabinsa to Highlight Research-supported Ingredients, Showcase New Beverage Concepts at IFIA Japan 2022

Sami-Sabinsa to Showcase Innovative, Clinically Studied Ingredients at VitaFoods Europe

Sami-Sabinsa Participates in Science Event Honoring the 70th Anniversary of Diplomatic Relations Between India and Japan

Certificates

Global Offices

Get in Touch

Disclaimer